Impact of Biologic Therapy on Key Cardiovascular Risk Parameters in a Psoriatic Cohort-a Retrospective Review.

Joseph JosephKelvin TruongSerigne N LoFiona FooSarah ZamanClara K ChowAnnika Smith

Published in: Dermatology and therapy (2024)

In patients with psoriasis, markers of cardiovascular disease risk did not improve after 1 year of biologic therapy despite significant improvements in psoriasis skin severity.

Keyphrases

rheumatoid arthritis
cardiovascular disease
type diabetes
disease activity
ankylosing spondylitis
metabolic syndrome
coronary artery disease
cell therapy